Lyophilization (Freeze-Drying)

Lyophilization — commonly called freeze-drying — is the process used to convert liquid peptide solutions into stable dry powders for long-term storage and shipping. Virtually every research peptide and many pharmaceutical peptides are delivered in lyophilized form.

Why lyophilize?

Peptides in solution are vulnerable to hydrolysis (water-mediated bond cleavage), oxidation, and microbial contamination. Removing water dramatically slows all three degradation pathways. A lyophilized peptide stored at −20°C can maintain >95% purity for years; the same peptide in solution at room temperature might degrade 30–50% in weeks.

The three phases

1. Freezing

The peptide solution is frozen to −40°C to −80°C. Ice crystals form, concentrating the peptide and any excipients (mannitol, sucrose, trehalose) in the interstitial spaces between crystals. The freezing rate matters: slow freezing produces large ice crystals (easier to sublime but more mechanical stress on the peptide); fast freezing produces small crystals (gentler on structure but slower to dry).

2. Primary drying (sublimation)

The chamber pressure is reduced to 50–200 mTorr and gentle heat is applied. Under these conditions, ice sublimates directly to vapor without passing through the liquid phase. This removes approximately 95% of the water. The temperature is kept below the product's collapse temperature — the point at which the partially dried matrix softens and loses its porous structure.

3. Secondary drying (desorption)

Temperature is raised (typically to 20–40°C) under continued vacuum to remove residual bound water from the peptide matrix. The target is typically <1–2% residual moisture. This phase is critical: too much residual water enables hydrolysis during storage; too aggressive drying can denature the peptide.

The cake and the plug

After lyophilization, the dried product appears as either a "cake" (a solid, porous plug that retains the shape of the frozen solution) or a "powder" (if the cake collapses or is intentionally crushed). A well-formed cake indicates that the product stayed below its collapse temperature during primary drying — generally a positive quality indicator, though cake appearance is not a reliable predictor of peptide purity.

Excipients and lyoprotectants

Most lyophilized peptide formulations include excipients that protect the peptide during freezing and drying:

• Mannitol: forms a crystalline matrix that provides cake structure
• Sucrose/Trehalose: amorphous sugars that hydrogen-bond to the peptide, replacing water molecules and stabilizing the native conformation
• Glycine: bulking agent that improves cake appearance

Reconstitution

When ready for use, lyophilized peptides are reconstituted by adding a diluent — typically bacteriostatic water (0.9% benzyl alcohol) or sterile water for injection. The porous cake structure facilitates rapid dissolution: gently swirl the vial rather than shaking (which can cause foaming and denaturation at the air-liquid interface).

The reconstituted solution returns to its original concentration if the same volume of diluent is added as was originally present before lyophilization — but in practice, researchers often reconstitute to their desired working concentration.